US Top Rating Updates on 8/24: TWTR, PLD, MDT, XPEV and More

Investment firm Rosenblatt downgraded $Twitter (Delisted)(TWTR.US)$ on Wednesday as the debate surrounding the whistleblower complaint from its former head of security has raised the risks surrounding the stock. Analyst Barton Crockett lowered his rating to neutral from buy and lowered his price target to $37 from $52, noting there are now "meaningful uncertainties" surrounding shares, especially as the company engages in a legal battle with Elon Musk.

A day after $Medtronic(MDT.US)$ shares dropped despite posting better than expected financials for 1Q FY23, Raymond James downgraded the MedTech company to Market Perform from Outperform on Wednesday, citing growth concerns in the second half of the fiscal year.

Barclays analyst Jiong Shao last night downgraded $XPeng(XPEV.US)$ to Equal Weight from Overweight with a price target of $22, down from $30. While the company's Q2 results were "solid," it provided "much weaker than expected" Q3 guidance on vehicle deliveries, Shao tells investors in a research note. Success of G9 will be critical to XPeng in both near and longer term, and execution risks are "heightened," says the analyst.